[HTML][HTML] Highly attenuated poxvirus-based vaccines against emerging viral diseases
Although one member of the poxvirus family, variola virus, has caused one of the most
devastating human infections worldwide, smallpox, the knowledge gained over the last 30 …
devastating human infections worldwide, smallpox, the knowledge gained over the last 30 …
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals
Mpox virus (MPXV) caused a multi-country outbreak in non-endemic areas in 2022.
Following historic success of smallpox vaccination with vaccinia virus (VACV)-based …
Following historic success of smallpox vaccination with vaccinia virus (VACV)-based …
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants
The accelerated development of the first generation COVID-19 vaccines has saved millions
of lives, and potentially more from the long-term sequelae of SARS-CoV-2 infection. The …
of lives, and potentially more from the long-term sequelae of SARS-CoV-2 infection. The …
[HTML][HTML] Viral-vectored boosting of OmcB-or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits …
TB Poston, J Girardi, AG Polson, A Bhardwaj… - Mucosal …, 2024 - Elsevier
A vaccine is needed to combat the Chlamydia epidemic. Replication-deficient viral vectors
are safe and induce antigen-specific T-cell memory. We tested the ability of intramuscular …
are safe and induce antigen-specific T-cell memory. We tested the ability of intramuscular …
[HTML][HTML] Rendezvous with Vaccinia Virus in the Post-smallpox Era: R&D Advances
Smallpox was eradicated in less than 200 years after Edward Jenner's practice of cowpox
variolation in 1796. The forty-three years of us living free of smallpox, beginning in 1979 …
variolation in 1796. The forty-three years of us living free of smallpox, beginning in 1979 …
Characterization and comparison of immunity against MPXV for individuals infected with MPXV or vaccinated with modified vaccinia Ankara vaccines
A Wiedemann, M Surénaud, M Hubert… - The Journal of …, 2025 - academic.oup.com
The 2022 Mpox virus (MPXV) outbreak revitalized questions about immunity against MPXV
and vaccinia-based vaccines (VAC-V), but studies are limited. We analyzed immunity …
and vaccinia-based vaccines (VAC-V), but studies are limited. We analyzed immunity …
Managing bacterial sexually transmitted infections (STIs) and preventing HIV/STIs in Europe
C Bébéar, S Pereyre, B Berçot… - The Lancet Regional …, 2023 - thelancet.com
HIV, viral hepatitis, and other sexually transmitted infections (STIs) are major public health
threats worldwide, and the WHO European Region is no exception. The WHO estimates that …
threats worldwide, and the WHO European Region is no exception. The WHO estimates that …
T-Cell Immunity in COVID-19-Recovered Individuals and Individuals Vaccinated with the Combined Vector Vaccine Gam-COVID-Vac
The COVID-19 pandemic has required extensive research on the new coronavirus SARS-
CoV-2 and the creation of new highly effective vaccines. The presence of T-cells in the body …
CoV-2 and the creation of new highly effective vaccines. The presence of T-cells in the body …
[PDF][PDF] Statistical methods for leveraging high-dimensional data from high-throughput measurements in vaccine clinical development
BP Hejblum - 2024 - hal.science
6 Directions for future research 71 6.1 Multi-modal data integration to enhance
measurement resolution. 71 6.2 Incorporating prior biological knowledge to enhance results …
measurement resolution. 71 6.2 Incorporating prior biological knowledge to enhance results …